Centre for Policy on Ageing
 

 

New drugs for Alzheimer's disease
Author(s)Roger Bullock
Journal titleBritish Journal of Psychiatry, vol 180, February 2002
Pagespp 135-139
KeywordsDrugs ; Dementia ; Research Reviews.
AnnotationThe anticholinesterase inhibitor (AChEI) class of drugs provides a major contribution to the therapeutic treatment of dementia, and is now endorsed by the National Institute for Clinical Excellence (NICE). A brief evidence-based review is made, which finds good evidence to support the use of AChEIs, and perhaps vitamin E. Oestrogen and anti-inflammatory agents show possibility, but there is not enough evidence to support routine use. (RH).
Accession NumberCPA-020219206 A
ClassmarkLLD: EA: 3A:6KC

Data © Centre for Policy on Ageing

...from the Ageinfo database published by Centre for Policy on Ageing.
 

CPA home >> Ageinfo Database >> Queries to: webmaster@cpa.org.uk